These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Preparation and characterization of polymorphs for an LTD4 antagonist, RG 12525. Carlton RA; Difeo TJ; Powner TH; Santos I; Thompson MD J Pharm Sci; 1996 May; 85(5):461-7. PubMed ID: 8742935 [TBL] [Abstract][Full Text] [Related]
3. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats. Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980 [TBL] [Abstract][Full Text] [Related]
4. Solid state characterization of E2101, a novel antispastic drug. Kushida I; Ashizawa K J Pharm Sci; 2002 Oct; 91(10):2193-202. PubMed ID: 12226846 [TBL] [Abstract][Full Text] [Related]
8. Polymorphism of sulindac: isolation and characterization of a new polymorph and three new solvates. Tros de Ilarduya MC; Martín C; Goñi MM; Martínez-Ohárriz MC J Pharm Sci; 1997 Feb; 86(2):248-51. PubMed ID: 9040104 [TBL] [Abstract][Full Text] [Related]
9. Thermal and X-ray powder diffraction structural characterization of two benfluorex hydrochloride polymorphs. Maccaroni E; Malpezzi L; Panzeri W; Masciocchi N J Pharm Biomed Anal; 2010 Sep; 53(1):1-6. PubMed ID: 20347245 [TBL] [Abstract][Full Text] [Related]
10. A quantitative model to evaluate solubility relationship of polymorphs from their thermal properties. Mao C; Pinal R; Morris KR Pharm Res; 2005 Jul; 22(7):1149-57. PubMed ID: 16028016 [TBL] [Abstract][Full Text] [Related]
11. Effects of solvents and crystallization conditions on the polymorphic behaviors and dissolution rates of valsartan. Tran TT; Tran PH; Park JB; Lee BJ Arch Pharm Res; 2012 Jul; 35(7):1223-30. PubMed ID: 22864745 [TBL] [Abstract][Full Text] [Related]
13. Characterization of nicergoline polymorphs crystallized in several organic solvents. Malaj L; Censi R; Capsoni D; Pellegrino L; Bini M; Ferrari S; Gobetto R; Massarotti V; Di Martino P J Pharm Sci; 2011 Jul; 100(7):2610-22. PubMed ID: 21254066 [TBL] [Abstract][Full Text] [Related]
14. The solid-state characterization of fusidic acid. Gilchrist SE; Letchford K; Burt HM Int J Pharm; 2012 Jan; 422(1-2):245-53. PubMed ID: 22100514 [TBL] [Abstract][Full Text] [Related]
15. [Investigation of thermal behaviors of γ-form nylon 6 prepared by ammonia vapor from phosphoric acid solutions]. Ge JW; Liu SX; Zhang CF; Li Q; Xia JM; Xu YZ; Wu JG Guang Pu Xue Yu Guang Pu Fen Xi; 2012 Jan; 32(1):118-22. PubMed ID: 22497141 [TBL] [Abstract][Full Text] [Related]
16. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying. Tian Y; Caron V; Jones DS; Healy AM; Andrews GP J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445 [TBL] [Abstract][Full Text] [Related]
17. Erythritol: crystal growth from the melt. Lopes Jesus AJ; Nunes SC; Ramos Silva M; Matos Beja A; Redinha JS Int J Pharm; 2010 Mar; 388(1-2):129-35. PubMed ID: 20045045 [TBL] [Abstract][Full Text] [Related]
18. Thermal and structural behavior of anhydrous milk fat. 3. Influence of cooling rate. Lopez C; Lesieur P; Bourgaux C; Ollivon M J Dairy Sci; 2005 Feb; 88(2):511-26. PubMed ID: 15653516 [TBL] [Abstract][Full Text] [Related]
19. Characterization and selective crystallization of famotidine polymorphs. Lu J; Wang XJ; Yang X; Ching CB J Pharm Sci; 2007 Sep; 96(9):2457-68. PubMed ID: 17518361 [TBL] [Abstract][Full Text] [Related]
20. A study of the changes during heating of paracetamol. de Wet FN; Gerber JJ; Lötter AP; van der Watt JG; Dekker TG Drug Dev Ind Pharm; 1998 May; 24(5):447-53. PubMed ID: 9876607 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]